AstraZeneca has admitted that its COVID-19 vaccine could cause a rare but deadly blood-clotting condition, potentially exposing the UK pharmaceutical giant to tens of millions in lawsuits brought ...

AstraZeneca to buy EsoBiotec for up to $1 billion Deal aims to enhance cancer cell therapy capabilities AstraZeneca secures global rights to Alteogen's ALT-B4 enzyme AstraZeneca shares up almost ...

AstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a plethora of new shots that has led to a decline in demand. The vaccine — called Vaxzevria and ...

Making wealth creation easy, accessible and transparent. AstraZeneca is the largest foreign owned pharmaceutical company in China based on revenue, and they’re continuing to increase investment ...

AstraZeneca AZN3.10%increase; green up pointing triangle has agreed to buy Gracell Biotechnologies for a transaction value of $1.2 billion, as part of the former’s efforts to grow its cell ...

A Utah mother who says she was “permanently disabled” after taking part in the US clinical trial of AstraZeneca’s COVID-19 vaccine is suing the drug manufacturer because it failed to cough ...

AstraZeneca, as part of its ongoing $3.5 billion investment in American innovation, opened its first U.S.-operated cell therapy factory in Maryland to help treat cancer patients. The U.K-based ...

Nov 1 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Wednesday it would invest $245 million in French biotechnology company Cellectis (ALCLS.PA), opens new tab in a deal aimed at speeding ...

AstraZeneca is capping out-of-pocket costs for inhalers and related medication at no more than $35 per month, the drugmaker announced Monday. The Britain based pharma giant said the expanded ...

AstraZeneca said Monday its experimental pill lowered "bad" LDL cholesterol by 51%. The results showed promise against rival drugs from Merck and NewAmsterdam Pharma, but AstraZeneca stock fell ...

Pharmaceutical giant AstraZeneca has blamed “user error” for leaving a list of credentials online for more than a year that exposed access to sensitive patient data. Mossab Hussein ...

The pharmaceutical giant AstraZeneca on Tuesday said it is withdrawing its COVID-19 vaccine worldwide citing low demand and a "surplus of available updated vaccines" since the pandemic.